ID   17-94
AC   CVCL_D704
SY   17.94; 17,94
DR   cancercelllines; CVCL_D704
DR   CancerTools; 153333
DR   Cosmic; 1716565
DR   DSMZ; ACC-741
DR   DSMZCellDive; ACC-741
DR   ECACC; 17100502
DR   Wikidata; Q54582323
DR   Ximbio; 153333
RX   PubMed=22749038;
CC   Doubling time: ~1 week (DSMZ=ACC-741).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Gly245Ser (c.733G>A); ClinVar=VCV000012365; Zygosity=Homozygous (PubMed=22749038).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): DSMZ=ACC-741; ECACC=17100502
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8
ST   D16S539: 11
ST   D18S51: 14,17
ST   D19S433: 12,14
ST   D21S11: 29
ST   D2S1338: 16,17
ST   D3S1358: 16
ST   D5S818: 11
ST   D7S820: 9,11
ST   D8S1179: 10,13
ST   FGA: 22,23
ST   Penta D: 9,11
ST   Penta E: 7,11 (ECACC=17100502)
ST   Penta E: 11 (DSMZ=ACC-741)
ST   TH01: 8,9.3
ST   TPOX: 8
ST   vWA: 14,16
DI   NCIt; C40407; Kidney Wilms tumor
DI   ORDO; Orphanet_654; Nephroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 02-05-24; Version: 21
//
RX   PubMed=22749038; DOI=10.1016/j.cancergen.2012.04.009;
RA   Brown K.W., Charles A., Dallosso A., White G., Charlet J.,
RA   Standen G.R., Malik K.;
RT   "Characterization of 17.94, a novel anaplastic Wilms' tumor cell
RT   line.";
RL   Cancer Genet. 205:319-326(2012).
//